Companies: 10,795·Total market cap: $144.5T
Clearside Biomedical, Inc.

Clearside Biomedical, Inc.

CLSDNASDAQHealthcare
$0.41
+$0.00(+0.00%)
Market Cap$2145948
P/E Ratio
52W High$17.1
52W Low$0.31
Overview

Clearside Biomedical, Inc.(CLSD)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

clsd · 股价预测 · 8 位分析师(近3月)· FMP · 更新于 2026年3月18日

分析师评级与共识

基于过去 3 个月内 8 位华尔街分析师

SellBuy

Buy

8 位分析师

共识

评级分布

Strong Buy
0
Buy
5
Hold
3
Sell
0
Strong Sell
0
合计: 8 · 买入占比: 62.5%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.30

Clearside Biomedical, Inc.(CLSD)的分析师共识为 Buy,基于过去 3 个月内 8 位华尔街分析师的评级。CLSD 的 12 个月平均目标价为 $0.00,相对当前价 $0.30 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.300.00%

1-day model range: $0.3–$0.3. Peak: $0.3 (+0.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

14%86%0%
2Buy
12Neutral
0Sell
RSI (14)50.0Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · CLSD · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.30BUY
MA 10$0.00NEUTRAL
MA 20$0.00NEUTRAL
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $CLSD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.29BUY
EMA 10$0.00NEUTRAL
EMA 20$0.00NEUTRAL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $CLSD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Needham2025-11-18
Maintains
HoldHold
HC Wainwright & Co.2025-07-18
Downgrade ↓
BuyNeutral
Chardan Capital2025-07-18
Downgrade ↓
BuyNeutral
Needham2025-07-17
Downgrade ↓
BuyHold
HC Wainwright & Co.2025-05-23
Maintains
BuyBuy
JMP Securities2025-05-16
Maintains
Market OutperformMarket Outperform
Needham2025-05-15
Maintains
BuyBuy
Needham2025-04-08
Maintains
BuyBuy
HC Wainwright & Co.2025-03-31
Maintains
BuyBuy
Citizens Capital Markets2025-03-28
Maintains
Market OutperformMarket Outperform

Wall Street analysts have recently issued updated ratings on Clearside Biomedical, Inc. (CLSD) stock. Of the recent 52 rating actions, 2 were upgrades and 3 were downgrades. 8 analysts currently cover CLSD.

分析师推荐趋势

Buy ratings303
Hold ratings01↑ +1
Sell ratings00

CLSD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$3M

↓ 81.3% YoY

Revenue Next Year

$7M

↑ 141.6% YoY

EPS This Year

$-4.65

EPS Next Year

$-3.30

↓ 29.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CLSD EPS of $-4.65 for the current fiscal year, based on estimates from 3 analysts. The CLSD revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CLSD 股价预测由两类独立数据源支撑:来自 8 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CLSD 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

CLSD 的短期预测(明日)为 $0.30(+0.00%)。

Clearside Biomedical, Inc. 在 NASDAQ 上市,代码 CLSD。CLSD 在 2027 年的整体展望偏积极,在覆盖分析师中约 63% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CLSD 预测 · 8 个问题

根据 8 位华尔街分析师,CLSD 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $0.30,隐含约 +0.0% 的上行空间。

CLSD 目标价CLSD 分析师目标价CLSD 12个月目标价目标价 CLSD

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.